Cargando…
New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
Since the pandemic’s onset, a growing population of individuals has recovered from SARS-CoV-2 infection and its long-term effects in some of the convalescents are gradually being reported. Although the precise etiopathogenesis of post-acute COVID-19 sequelae (PACS) remains elusive, the mainly accept...
Autores principales: | Rapti, Vasiliki, Tsaganos, Thomas, Vathiotis, Ioannis A., Syrigos, Nikolaos K., Li, Peifeng, Poulakou, Garyfallia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611551/ https://www.ncbi.nlm.nih.gov/pubmed/36298472 http://dx.doi.org/10.3390/vaccines10101607 |
Ejemplares similares
-
Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence?
por: Trontzas, Ioannis P., et al.
Publicado: (2022) -
Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities
por: Tsiakos, Konstantinos, et al.
Publicado: (2022) -
Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
por: Trontzas, Ioannis P., et al.
Publicado: (2022) -
Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis
por: Sharma, Tarang, et al.
Publicado: (2022) -
Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
por: Petrakis, Vasilis, et al.
Publicado: (2022)